Biogen Inc.BIIBNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-7.92%
↓ 252% below average
Average (9y)
5.21%
Historical baseline
Range
High:63.53%
Low:-24.95%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -7.92% |
| 2023 | 4.07% |
| 2022 | -23.63% |
| 2021 | -24.95% |
| 2020 | 63.53% |
| 2019 | 2.24% |
| 2018 | 14.16% |
| 2017 | 20.29% |
| 2016 | -1.96% |
| 2015 | 6.31% |